Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor 12/4/2023

J&J Hires Thousands, Invests Millions in AI-Powered Drug Discovery 12/4/2023

Moving RNA Therapeutics Beyond the Liver 12/4/2023

Opinion: The Transformative Potential of Gene Therapy for Neurodegenerative Diseases 12/4/2023

FDA Action Alert: Vertex/CRISPR, Arcutis and Optinose 12/4/2023

Holmes to Remain in Prison While Appeal Plays Out 4/12/2023

Aeglea Cuts Majority of Staff Following Mixed Trial Results 4/12/2023

Moderna’s Flu Shot Falls Short of Early Success Threshold 4/12/2023

With Positive Phase III Data, Junshi's PARP Inhibitor could Challenge Lynparza 4/12/2023

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.

A prototype using The University of Queensland-developed and Vaxxas-commercialised high-density microarray patch (HD-MAP) has delivered a University of Adelaide-developed vaccine and elicited an effective immune response to Zika virus in mice.

ADC and GLP-1 Rocket Ride Continues as 2023 Comes to Close 12/1/2023

Pfizer Nixes Twice-Daily Oral GLP-1 Candidate After High Rates of Side Effects 12/1/2023

Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News 12/1/2023

AstraZeneca Axes Two Phase III Hyperkalemia Trials for Lokelma 12/1/2023

GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status 12/1/2023

Astellas Touts Phase III Data for Menopause Drug, Eyes European Reimbursement 12/1/2023

AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval 12/1/2023

University of Virginia School of Medicine researchers have discovered how Lactobacillus, a bacterium found in fermented foods and yogurt, helps the body manage stress and may help prevent depression and anxiety. The findings open the door to new therapies to treat anxiety, depression and other mental-health conditions.

The new research from UVA's Alban Gaultier, Ph.D., and collaborators is notable because it pinpoints the role of Lactobacillus, separating it out from all the other microorganisms that naturally live in and on our bodies.

Hurdle, a pioneer in diagnostic testing, and the Consumer Health division of Bayer have launched a strategic partnership to advance consumer innovations in the emerging area of healthy aging. The partnership is designed to enhance the companies' shared ambition to transform self-care through personalized solutions.

The U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas.